Key Takeaways
- Some people with multiple sclerosis (MS) are at higher risk for severe COVID-19 and are therefore eligible for early vaccination.
- According to the National Multiple Sclerosis Society, both the Moderna and Pfizer-BioNTech vaccines are safe for people with MS. The organization has not yet made a decision about the Janssen/Johnson & Johnson vaccine.
- If you have MS, talk to your doctor before getting vaccinated—especially if you are being treated with disease-modifying therapies (including Ocrevus, Lemtrada, Rituximab, Mavenclad, and Kesimpta) which may reduce the effectiveness of the COVID-19 vaccine.
If you have multiple sclerosis (MS), you might be wondering if the condition places you at increased risk for COVID-19 and whether you will be eligible to receive a vaccine soon. While the answer is usually yes, you will need to discuss the vaccine with your doctor, especially if you are receiving certain MS treatments.
Julie Fiol, RN, the director of MS information and resources for the National Multiple Sclerosis Society (NMSS), tells Verywell that some of the indirect effects of MS and its treatment can increase a person’s risk for COVID-19.
Although MS itself isn’t a risk factor for COVID-19, Fiol says that “certain factors associated with” it are. These include obesity, severe disability, heart conditions, and lung conditions.
- Men with MS
- People with progressive MS
- Black and possibly South Asian people with MS
- People over the age of 60 with MS